DENTSPLY SIRONA Inc. (XRAY): who owns it and who trades it
As of Nov 16, 2026, XRAY insiders reported 1 open-market sale worth $916K and 12 purchases worth $1.7M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Gregory T Lucier (Director), with $916K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Dentsply Sirona
From the latest filingsOverall: more buying than selling. Famous investors mostly sold. Insiders mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns XRAY
371 funds and institutions reported XRAY shares worth $2.4B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 13.3%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 26.71M | 13.33% | $283M | +39% |
| Fuller & Thaler Asset Management, Inc. | 12.70M | 6.34% | $135M | -1% |
| Vanguard Portfolio Management LLC | 11.78M | 5.88% | $125M | +12% |
| AQR Capital Management LLC | 10.46M | 5.22% | $110M | +164% |
| State Street Corp | 9.29M | 4.64% | $98.5M | +28% |
| Vanguard Capital Management LLC | 9.05M | 4.52% | $96M | +1% |
| Lazard Asset Management LLC | 8.27M | 4.13% | $87.7M | +23% |
| Ariel Investments, LLC | 8.03M | 4.01% | $85.2M | +26% |
| Southpoint Capital Advisors LP | 7.00M | 3.49% | $74.3M | -30% |
| Cooke & Bieler LP | 6.93M | 3.46% | $73.5M | -11% |
| Geode Capital Management, LLC | 5.65M | 2.82% | $60M | +48% |
| Invenomic Capital Management LP | 4.91M | 2.45% | $52.1M | +12% |
| Edmond DE Rothschild Holding S.a. | 4.50M | 2.25% | $47.8M | +8% |
| Jupiter Asset Management Ltd | 4.50M | 2.24% | $47.7M | +457% |
| Allianz Asset Management GmbH | 3.82M | 1.91% | $40.6M | +30% |
| Marshall Wace, LLP | 3.80M | 1.90% | $40.3M | -16% |
| Paradigm Capital Management Inc | 3.75M | 1.87% | $39.8M | +26% |
| Armistice Capital, LLC | 3.67M | 1.83% | $39M | +22% |
| Dimensional Fund Advisors LP | 3.46M | 1.73% | $36.7M | -3% |
| D. E. Shaw & Co., Inc. | 2.99M | 1.49% | $31.7M | +23% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, XRAY insiders reported $1.7M of open-market purchases and $916K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Clyde Hosein | Director | Purchase | 6,500 | $9.99 | $64.9K | Form 4 |
| Jun 15, 2026 | Brian T Gladden | Director | Purchase | 9,985 | $10.02 | $100K | Form 4 |
| Jun 12, 2026 | Jonathan Jay Mazelsky | Director | Purchase | 10,000 | $10.14 | $101K | Form 4 |
| Jun 12, 2026 | Brian P Mckeon | Director | Purchase | 10,000 | $10.12 | $101K | Form 4 |
| Jun 11, 2026 | Betsy D Holden | Director | Purchase | 10,086 | $9.88 | $99.6K | Form 4 |
| Jun 11, 2026 | Michael J Barber | Director | Purchase | 15,175 | $9.89 | $150K | Form 4 |
| Mar 9, 2026 | Gregory T Lucier | Director | Purchase | 15,000 | $12.45 | $187K | Form 4 |
| Mar 9, 2026 | James D Forbes | Director | Purchase | 5,000 | $12.48 | $62.4K | Form 4 |
| Mar 3, 2026 | Gregory T Lucier | Director | Purchase | 22,445 | $14.03 | $315K | Form 4 |
| Mar 3, 2026 | James D Forbes | Director | Purchase | 5,000 | $13.47 | $67.3K | Form 4 |
| Mar 2, 2026 | Gregory T Lucier | Director | Purchase | 27,555 | $14.25 | $393K | Form 4 |
| Dec 8, 2025 | Gregory T Lucier | Director | Sale | 82,200 | $11.14 | $916K | Form 4 |
| Nov 24, 2025 | Leslie F Varon | Director | Purchase | 9,337 | $10.71 | $100K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Gregory T Lucier | Director | $894K | $916K | Mar 9, 2026 |
| Michael J Barber | Director | $150K | – | Jun 11, 2026 |
| James D Forbes | Director | $130K | – | Mar 9, 2026 |
| Jonathan Jay Mazelsky | Director | $101K | – | Jun 12, 2026 |
| Brian P Mckeon | Director | $101K | – | Jun 12, 2026 |
| Brian T Gladden | Director | $100K | – | Jun 15, 2026 |
| Leslie F Varon | Director | $100K | – | Nov 24, 2025 |
| Betsy D Holden | Director | $99.6K | – | Jun 11, 2026 |
| Clyde Hosein | Director | $64.9K | – | Jun 15, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
XRAY short interest
High short interest. 13.2% of XRAY shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 10%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 26.16M XRAY shares were sold short, 13.2% of the shares outstanding, down 12.3% from the report before. At the average daily volume of 4.11M shares, buying them all back would take about 6.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 26.16M | 13.20% | -12% | 4.11M | 6.4 |
| Oct 15, 2026 | 29.82M | 14.96% | +17% | 4.83M | 6.2 |
| Sep 30, 2026 | 25.53M | 12.81% | +4% | 5.72M | 4.5 |
| Sep 15, 2026 | 24.59M | 12.33% | +11% | 3.56M | 6.9 |
| Aug 31, 2026 | 22.09M | 11.08% | +12% | 3.43M | 6.4 |
| Aug 14, 2026 | 19.68M | 9.87% | -17% | 5.18M | 3.8 |
| Jul 31, 2026 | 23.60M | 11.84% | -21% | 4.97M | 4.8 |
| Jul 15, 2026 | 29.94M | 14.94% | +2% | 5.03M | 6.0 |
| Jun 30, 2026 | 29.22M | 14.59% | +18% | 7.60M | 3.9 |
| Jun 15, 2026 | 24.72M | 12.34% | +13% | 4.34M | 5.7 |
| May 29, 2026 | 21.88M | 10.92% | -8% | 7.02M | 3.1 |
| May 15, 2026 | 23.70M | 11.83% | +11% | 6.15M | 3.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded XRAY
Since Nov 17, 2024, 1 member of Congress reported 0 purchases and 2 sales of XRAY. The latest was a sale by Gilbert Ray Cisneros, Jr. on Jan 8, 2025, reported Feb 11, 2025.
Purchases 0Sales 2
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Jan 8, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Sale | $1K–$15K | Self | Feb 11, 2025 | Report |
| Jan 7, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Feb 11, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Dentsply Sirona company events
Dentsply Sirona filed 12 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Oct 9, 2026AgreementDENTSPLY SIRONA Inc. obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Third Amendment to Credit Agreement, dated as of… Filing
- Aug 7, 2026ResultsAmended an earlier report. Released financial results. Filing
- Jun 11, 2026LeadershipThe Board of Directors of DENTSPLY SIRONA Inc. appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026. Filing
- Jun 4, 2026VoteReported shareholder vote results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Feb 24, 2026LeadershipUpon the recommendation of the Corporate Governance and Nominating Committee of the Board of Directors of DENTSPLY SIRONA Inc., and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 11 to 13. Filing
- Jan 14, 2026AnnouncementShared information with investors. Filing
- Jan 13, 2026LeadershipUpon the recommendation of the Corporate Governance and Nominating Committee of the Board of Directors of DENTSPLY SIRONA Inc., and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 10 to 11, effective immediately. Filing
- Dec 31, 2025AgreementDENTSPLY SIRONA Inc. obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Second Amendment to Credit Agreement, dated as… Filing
- Nov 25, 2025AnnouncementDENTSPLY SIRONA Inc. announced the appointment of Michael Pomeroy as the Company’s interim Chief Financial Officer, who will serve in this temporary capacity until the Company identifies and appoints a permanent Chief Financial Officer. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Dentsply Sirona financials
Famous investors that hold XRAY
5 of the 50 well-known investors we track reported holding XRAY in their latest 13F filing. The largest position is Ray Dalio's, worth $5.9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ray Dalio · Bridgewater Associates | Q3 2026 | 661,526 | $5.9M | 0.0% | +79% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 587,558 | $5.2M | 0.0% | +1656% |
| Israel Englander · Millennium Management | Q3 2026 | 406,158 | $3.6M | 0.0% | -53% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 339,795 | $3M | 0.0% | -55% |
| Cathie Wood · ARK Investment Management | Q3 2026 | 207,727 | $1.8M | 0.0% | -12% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named XRAY in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | FULLER & THALER ASSET MANAGEMENT, INC. | 13G/A | 4.9% |
| Nov 16, 2026 | FULLER & THALER ASSET MANAGEMENT, INC. | 13G/A | 4.9% |
Questions about DENTSPLY SIRONA Inc. (XRAY) stock
Who owns the most XRAY stock?
The largest reported owner of DENTSPLY SIRONA Inc. (XRAY) is BlackRock, Inc., with 13.3% of the company. In total, 371 funds and institutions reported holding XRAY at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are XRAY insiders buying or selling?
In the last 12 months, XRAY insiders reported 12 open-market purchases worth $1.7M and 1 sale worth $916K. The latest trade was on Jun 15, 2026. See every trade.
What is the short interest in XRAY?
As of Oct 30, 2026, 26.16M XRAY shares were sold short, 13.2% of the shares outstanding, down 12.3% from the report before. At the average daily volume of 4.11M shares, buying them all back would take about 6.4 trading days (days to cover). See the history.
Have members of Congress traded XRAY?
Yes. 1 member of Congress reported 0 purchases and 2 sales of XRAY since Nov 17, 2024. The latest was reported on Feb 11, 2025. See the trades.
Which famous investors hold XRAY?
5 of the 50 well-known investors we track reported XRAY in their latest 13F filing, including Ray Dalio, Jim Simons, Israel Englander. The largest position is worth $5.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.